Podcasts about d innovation

Legal teams work best when their operations run smoothly and efficiently, and developing innovations must be kept in mind as teams hone their legal operations strategies. Dennis and Tom talk with legal tech experts Amy Brookbanks and Michael Kennedy about their work helping lawyers and in-house legal teams work through problems with effective technology solutions. They discuss strategies for defining necessities in workflows to help lawyers understand how to implement technology to optimize their practices. They also discuss their career paths in the legal field and discuss current happenings in tech, AI, collaboration, and much more. As always, stay tuned for the parting shots, that one tip, website, or observation that you can use the second the podcast ends. Have a technology question for Dennis and Tom? Call their Tech Question Hotline at 720-441-6820 for the answers to your most burning tech questions.   Amy Brookbanks is Legal Operations Consultant at Addleshaw Goddard. Michael Kennedy is head of R&D (Innovation & Legal Technology) at Addleshaw Goddard.  Show Notes: Addleshaw Goddard LLP Tech Talks | Addleshaw Goddard LLP LinkedIn - Amy Brookbanks LinkedIn - Michael Kennedy Innovation Graduate Scheme 2025 Braintoss Retrospectives with OneNote  Tom and Dennis on Video! Copilot Legal AI Live on LinkedIn the second Friday of every month TextExpander Learn more about your ad choices. Visit megaphone.fm/adchoices

Legal teams work best when their operations run smoothly and efficiently, and developing innovations must be kept in mind as teams hone their legal operations strategies. Dennis and Tom talk with legal tech experts Amy Brookbanks and Michael Kennedy about their work helping lawyers and in-house legal teams work through problems with effective technology solutions. They discuss strategies for defining necessities in workflows to help lawyers understand how to implement technology to optimize their practices. They also discuss their career paths in the legal field and discuss current happenings in tech, AI, collaboration, and much more. As always, stay tuned for the parting shots, that one tip, website, or observation that you can use the second the podcast ends. Have a technology question for Dennis and Tom? Call their Tech Question Hotline at 720-441-6820 for the answers to your most burning tech questions.   Amy Brookbanks is Legal Operations Consultant at Addleshaw Goddard. Michael Kennedy is head of R&D (Innovation & Legal Technology) at Addleshaw Goddard.  Show Notes: Addleshaw Goddard LLP Tech Talks | Addleshaw Goddard LLP LinkedIn - Amy Brookbanks LinkedIn - Michael Kennedy Innovation Graduate Scheme 2025 Braintoss Retrospectives with OneNote  Tom and Dennis on Video! Copilot Legal AI Live on LinkedIn the second Friday of every month TextExpander Learn more about your ad choices. Visit megaphone.fm/adchoices

Summary In this episode, Mike Smith and Ryan Roghaar interview Jon Morris, CEO and founder of Fiscal Advocate, discussing his entrepreneurial journey, the evolution of a CEO, the importance of mentorship, and the decision-making process in business. Jon shares insights on goal setting, differentiation in a crowded market, and the significance of sales and marketing budgets. He emphasizes the need for constant innovation and the importance of tracking success through metrics and KPIs. Takeaways Surrounding yourself with mentors is crucial for growth. The role of a CEO evolves as the company grows. Execution is often more challenging than generating ideas. Setting clear goals and budgets is essential for success. Differentiation in a crowded market requires unique value propositions. Decision-making is a blend of data and instinct. Investing in innovation is key to staying competitive. Sales and marketing budgets should be prioritized for growth. Tracking metrics helps in understanding business performance. Building a product requires constant feedback and iteration. Chapters 00:00 Introduction to John Morris and His Journey 03:22 The Evolution of a CEO: Stages of Growth 06:06 Learning from Experience: Mentorship and Growth 09:02 Deciding to Exit: The Sale of Rise Interactive 12:14 Executing Ideas: The Challenge of Implementation 14:59 Goal Setting and Accountability in Business 18:05 Differentiation in a Crowded Market: Rise Interactive's Strategy 28:15 Recruiting for Success: The Finance Advantage 29:42 Data-Driven Marketing: The Analytics Revolution 31:53 Differentiation: The Two Question Test 35:51 Decision Making: Balancing Data and Instinct 42:22 R&D: Innovation in Service-Based Businesses 52:35 Sales and Marketing: Finding the Right Spend Credits: Hosted by Michael Smith and Ryan Roghaar Produced by Ryan Roghaar Theme music: "Perfect Day" by OPM  The Carton: ⁠⁠⁠⁠⁠https://medium.com/the-carton-by-eggs⁠⁠⁠⁠⁠ Feature with Zack Chmeis of Straight Method up now!  ⁠⁠⁠⁠⁠https://medium.com/the-carton-by-eggs/zack-chmeis-35dae817ac28⁠⁠⁠⁠⁠   The Eggs Podcast Spotify playlist: bit.ly/eggstunes The Plugs: The Show eggscast.com @eggshow on twitter and instagram On iTunes: itun.es/i6dX3pCOn Stitcher: bit.ly/eggs_on_stitcher Also available on Google Play Music! Mike "DJ Ontic": Shows and info: ⁠⁠⁠⁠⁠djontic.com⁠⁠⁠⁠⁠ @djontic on twitter Ryan Roghaar: ⁠⁠⁠⁠⁠http://rogha.ar⁠⁠⁠⁠⁠

Part 4 of 4: Jon Chee hosts Barry Ticho, Founder of Verve Therapeutics and Chief Medical Officer at Stoke Therapeutics, a biotech company addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines. With an MD PhD from the University of Chicago and extensive experience across academia and industry, Barry brings over two decades of expertise in clinical development. His journey includes roles as Head of Development at Moderna, Head of External R&D Innovation at Pfizer, and VP of Clinical Development at Biogen, where he's been instrumental in advancing numerous therapeutic programs across multiple disease areas. Barry's unique perspective spanning academic medicine and biotechnology innovation makes his insights invaluable for aspiring leaders in the field.

Part 3 of 4: Jon Chee hosts Barry Ticho, Founder of Verve Therapeutics and Chief Medical Officer at Stoke Therapeutics, a biotech company addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines. With an MD PhD from the University of Chicago and extensive experience across academia and industry, Barry brings over two decades of expertise in clinical development. His journey includes roles as Head of Development at Moderna, Head of External R&D Innovation at Pfizer, and VP of Clinical Development at Biogen, where he's been instrumental in advancing numerous therapeutic programs across multiple disease areas. Barry's unique perspective spanning academic medicine and biotechnology innovation makes his insights invaluable for aspiring leaders in the field.

Part 2 of 4: Jon Chee hosts Barry Ticho, Founder of Verve Therapeutics and Chief Medical Officer at Stoke Therapeutics, a biotech company addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines. With an MD-PhD from the University of Chicago and extensive experience across academia and industry, Barry brings over two decades of expertise in clinical development. His journey includes roles as Head of Development at Moderna, Head of External R&D Innovation at Pfizer, and VP of Clinical Development at Biogen, where he's been instrumental in advancing numerous therapeutic programs across multiple disease areas. Barry's unique perspective spanning academic medicine and biotechnology innovation makes his insights invaluable for aspiring leaders in the field.

Part 1 of 4: Jon Chee hosts Barry Ticho, Founder of Verve Therapeutics and Chief Medical Officer at Stoke Therapeutics, a biotech company addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines. With an MD-PhD from the University of Chicago and extensive experience across academia and industry, Barry brings over two decades of expertise in clinical development. His journey includes roles as Head of Development at Moderna, Head of External R&D Innovation at Pfizer, and VP of Clinical Development at Biogen, where he's been instrumental in advancing numerous therapeutic programs across multiple disease areas. Barry's unique perspective spanning academic medicine and biotechnology innovation makes his insights invaluable for aspiring leaders in the field.

In this episode, Karina Zimerfeld, global vice president of R&D for Mars Food & Nutrition, discusses how her company is aiming to help at-home cooks address the three primary demands they have when it comes to meal planning and preparation. Zimerfeld also talks about the technologies that have opened the door for companies to more easily address consumer demands today, and how Mars Food & Nutrition has begun to tap into artificial intelligence to analyze trends in support of its R&D work to stay on top of — or even ahead of — consumer preferences.

Pauline Rebourgeon and Peter Sheppard from Ericsson discuss how they are innovating with AI for learning and development. They outline how Ericsson's Learning NEXT community fosters a culture of experimentation with emerging technologies to support learning and development. Pauline and Peter discuss the importance of community in scaling these efforts, and the strategic balance between quick wins and long-term impact. The episode highlights practical examples such as AI-based translation and coaching tools, underscoring the value of starting small and pivoting as needed to meet evolving business needs. Host: Michelle Ockers Transcript and related resources: https://learninguncut.global/podcast/152/ Podcast information and more episodes: https://learninguncut.global/podcast/

How can you create a product-engineering organization that's profitable? Where growth is aligned with business needs; where engineers don't do tech for tech's sake; where value is the first… value? This week's podcast episode is a quick recap of topics from my four-part series about such organizations. Tune in to create a team worth leading.The articles in the series:Highly Profitable Engineering TeamsMaking Profitable SoftwareProfitable R&D Structure and GrowthR&D Innovation for Fun and ProfitGrab a copy of my books, Capitalizing Your Technology and  The Tech Executive Operating System.Subscribe to the best newsletter for tech executives.For any questions or comments, reach out to me directly: aviv@avivbenyosef.com

Meghan Clancy, R&D Specialist at Standard Meat, outlines how her background in animal science helps promote communication and teamwork among R&D practitioners at this Texas-based multi-protein processing firm. Clancy also describes her team's focus on meeting the needs of customers looking for custom and specialized processing services in an attempt to stay up to date on changing industry innovations, flavors and practices. 

This week Thomas Slattery spoke with Daniel Purkiss and Sam Todd at Leyton, the UK's leading specialist innovation funding consultancy.Leyton supports a significant proportion of the UK's agriculture-related R&D claims each year, helping hundreds of businesses in farming and the supply chain through to engineering and technology providers, increase their ability to fund future projects and grow.Their team of in-house consultants, which includes scientists, engineers and software developers who understand the agri-food sector, have over a decade of experience working with food producers, processors and retailers across the UK. Leyton helps them benefit from valuable schemes, including R&D Tax Credits, Grants and the Patent Box Scheme, which allows qualifying companies to accelerate their innovation strategy through additional funding and/or a reduction in their corporation tax.

In Ep. 84, we'll discuss how Meghan Clancy, R&D Specialist at Standard Meat, relies on her background in animal science to help promote  communication and teamwork among R&D practitioners at this , Texas-based multi-protein processor. Clancy also is focused on meeting the needs of customers who often are looking for custom and specialized processing services who also are required to stay up to date on changing industry innovations and practices. 

Dr. Uwe Schoenbeck, Ph.D., (https://www.pfizer.com/research/science_and_technology/meet_our_scientists/uwe_schoenbeck) is Chief Scientific Officer, Emerging Science & Innovation (ES&I) and Senior Vice President, Worldwide Research and Development & Medical (WRDM) at Pfizer. Part of Worldwide Research, Development & Medical, ES&I is charged with enhancing Pfizer's pipeline through translation of external emerging science into breakthrough therapies for patients and through dedicated outreach to academia, consortia and biotech. Through its Emerging Science Liaisons located around the globe, they work across Pfizer's Therapeutic Areas to harness external cutting edge pre-clinical assets and breakthrough technologies applying a broad range of partnering vehicles, including research collaborations, consortia, licensing, and acquisitions. ES&I also engages in equity investments as well as seed investments and formation of new companies. It has a Target Sciences team which is focused on novel target and biology discovery research to introduce differentiated First-in-Class programs with enhanced confidence in rationale into the WRDM portfolio. And through its new Centers for Therapeutic Innovation (CTI - https://www.pfizercti.com/), ES&I prosecutes cutting edge science sourced from leading academic and medical centers globally, working in close partnership with external PIs and building an exciting pipeline across the range of Pfizer's core areas. Dr. Schoenbeck brings fifteen years of pharmaceutical drug development experience to Pfizer's R&D executive leadership team. Prior to joining the company, he served as Vice President, Emerging R&D Innovation for Wyeth and Vice President, Cardiovascular Research for Boehringer Ingelheim. Before joining industry, he held an Assistant Professor of Medicine position at Brigham & Women's Hospital, Harvard Medical School. He has served as a reviewer for multiple peer-reviewed journals and has published more than 100 peer-reviewed articles, review articles, book chapters and abstracts with particular contributions in molecular and cell biology, cardiovascular research, immunology and metabolism. Dr. Schoenbeck earned his Ph.D. from the University of Kiel, Germany, and completed postdoctoral training in the Division of Cardiovascular Medicine, Brigham & Women's Hospital, Harvard Medical School, before joining as a faculty member.

Show description Welcome to Dreaming in Color, a show that provides a platform for BIPOC social change leaders to candidly share how their lived experiences (personal and professional) have prepared them to lead their work and drive the impact we all seek.  In this episode, Raymond Foxworth joins the show to talk about his experience growing up in a matrilineal society, land preservation as part of his family heritage and the struggles of dealing with white dominant institutions. We address the current state of indigenous land rights and the pressure of representation to honor the legacy and sacrifice of past generations. Raymond shares his view on innovation and we question the general understanding of community development. Listen and connect with Ray's philosophy of believing and sharing! Jump straight into: (01:23) - Raymond reads Apologies, a poem by Haunani Kay Trask (and shares the breathtaking story behind it). (03:10) - Being a Navajo citizen in 2022: Matrilineal society roots, ethics, values, decisive moments to acquire critical analysis. (09:18) - Addressing colonialism struggles, sovereignty, liberation and Indigenous land rights. (12:50) - Acknowledging representation, role models and implications when navigating white dominant institutions. (20:03) - Innovation as a product of survival, problems within society's general understanding of community development and redefining what we conceive as assets. (27:32) - Believing and caring: The experiences that bring hope to Ray, a protective optimist. Episode resources Connect with Raymond Foxworth through https://www.linkedin.com/in/raymond-foxworth/ (LinkedIn) Learn more about https://www.rayfoxworth.com/ (Ray Foxword, Ph.D.) Learn more about https://www.linkedin.com/company/first-nations-development-institute/ (First Nations Development Institute)  Thank you for listening to Dreaming in Color a https://www.bridgespan.org/ (Bridgespan) supported https://www.studiopodsf.com/ (StudioPod) production. Nicole Genova is the Show Coordinator and Teresa Buchanan is the Show Producer. The production team from The Bridgespan Group includes Cora Daniels, Michael Borger, Christina Pistorius, and Britt Savage. Additional music and editing provided by https://nodalab.com/ (nodalab).

As Chief Medical Officer Dr. Ticho is responsible for Stoke's efforts to develop first-in-class RNA based disease-modifying medicines to treat severe genetic diseases. He is also co-founder and former CEO of Verve Therapeutics which is developing therapies to edit the genome and confer protection from cardiovascular disease. Prior to joining Stoke Barry was Head of R&D for Cardiovascular and Metabolic Diseases at Moderna Therapeutics. He was previously Head of External R&D Innovation for Cardiovascular and Metabolic Diseases at Pfizer. Prior to that he was Vice President of Clinical Development at Biogen where he led clinical development for the Tysabri program for MS and led the aducanumab program for Alzheimer's Disease. Barry obtained his M.D. and Ph.D. degrees from the University of Chicago and completed Pediatrics training at Northwestern University and a Cardiology fellowship at Children's Hospital in Boston. He was on clinical staff at Harvard Medical School and Massachusetts General Hospital.

Pourquoi n'y a-t-il pas d'Elon Musk français? La question agite périodiquement le Landerneau politico-journalistique français. Dans cet épisode, je montre que l'une des raisons principales est le développement de deux modèles mentaux dans notre pays: une méfiance envers la technologie et un pessimisme sur l'avenir.

Wanna get ready to think “out of the box” to support Innovation Teams in your R&D organizations…? Maybe a little refresher or primer on Design Thinking as part of the Innovation process...? If so, then listen in to thoughts and tangible tips from my colleague @Susan Mayer, Innovation Lead Food/Ag at RTI Innovation Advisers and a former leader at several CPG companies. PS. Susan is a Certified Food Scientist with tons of business application knowledge…! As always, thank you for your support Listeners...! --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/denise-venneri/support

Lokesh was born in Agra, India. Known for the 7th wonder of the world, the Taj Mahal. He had a very small family and at a young age he was interested in cosmetics. He would look into the ingredients and later in life start to lo9 more into the medical aspects. In high school he started to look into what he needed to do to be a doctor. By the time he graduated he had decided to go into the pharmaceutical side. He got into the pharmacy college and graduated with a degree in pharmaceutical chemistry.He started working in the pharmaceutical industry with injectables -cosmetic and antiviral. Later on, he applied for a job for a research and development position. They asked if he would be interested in being in the cosmetic division. He worked with cosmetics and went to work with clean ingredients for cosmetics and beauty products.In 2001 he came to the US and ended up in Northern California. He started out as a junior chemist. He had made many findings and worked to create many great products. He alsoworked in many different areas from customer service and problem solving. This gave him lots of experience to help him start his own business later.In 2018, Lokesh started his own company. Nilokj Inc. was born in 2018 by Lokesh K. Jain & his better half Nidhi Jain for providing consulting services in research and developmentinnovation of personal care products (skin/body/hair) to commercial andIndie/Niche market brands especially with natural-clean culture philosophyusing most currently available upcycled, natural-clean commoditiesingredients and clinically tested cosmetics active ingredients. Nilokj's R&Dis headed by Lokesh K. Jain, who brought his broad 23 years of hand onresearch, development and innovation experience covers all spectrum ofLokesh K. Jain conventional/natural based personal care formulation development. R&D-Innovation's Consulting services are focused and targeted towards high-end skin care (natural-clean and conventional) including OTC/Topical drug products.Thanks for listening! Thanks so much for listening to our podcast! If you enjoyed this episode and think that others could benefit from listening, please share it using the social media buttons on this page.Do you have some feedback or questions about this episode? Leave a comment in the section below!Subscribe to the podcast If you would like to get automatic updates of new podcast episodes, you can subscribe to the podcast on Apple Podcastsor Stitcher. You can also subscribe inyour favorite podcast app.Leave us an Apple Podcasts review Ratings and reviews from our listeners are extremely valuable to us and greatly appreciated. They help our podcast rank higher on Apple Podcasts, which exposes our show to more awesome listeners like you. If you have a minute, please leave an honest review on Apple Podcasts.

Chaque jour, Patrick Cohen reçoit dans son journal de la mi-journée un invité. Aujourd’hui, Frédéric Tangy.

durée : 00:58:45 - Les Cours du Collège de France - Comment les termes de l’émancipation économique, sociale et politique ont-ils été radicalement modifiés par trois grandes mutations contemporaines ? demande Pierre Rosanvallon. - réalisation : Anne Sécheret

Day 2 of the HR and L&D Innovation and Tech Fest has shed light on how #hrtech has been changing for the past 10 years, and the 2020 pandemic has served as an accelerant.It was exhilarating to catch up with Jason Averbook and discuss how companies need to be even more agile in the #nowofwork and learn to simultaneously play offense and defense. Work-life integration requires us to look beyond the work that people are doing and focus in on the holistic, human experience. This is what will drive a true #digitaltransformation. It’s about transparency. 100% of the time. It’s a blend life. A huge thanks to having Jarrod McGrath from SmartWFM tune in and share his take on making work more human. If you missed the conference, stay tuned for more great highlights!#HR #humanresources #hrtechnology #HRTechFest #LDTECHFEST #digitaltransformation #digitalworkforce #futureofwork #NowofWork #leadership #asiapacific #australia #globalimpact #hrconsulting #mentalhealth #futureplanning #hrleadership #innovation

I hope you’ve been enjoying the HR + L&D Innovation & Tech Fest. The first day was action-packed! If you didn’t get to all the sessions, check out our HumansofHR recap with David Guazzarotto and Michelle Farrar-Eagles where we recap Day 1 of the virtual conference and share our thoughts on a range of topics from AI to the Role of HR to Mental Health and much more.Recording live from conferences has been our thing over the years, though it's not quite the same as being there we hope to have captured the vibe for those of you who haven't been able to get to the sessions.

Capgemini est positionné comme l’un des leaders du « Magic Quadrant for Public Cloud Infrastructure Professional and Managed Services, Worldwide » de Gartner pour son approche complète et sa capacité d’exécution. Guy Michel Pambi, chargé de l’offre stratégie Cloud chez Capgemini Invent et Thomas Sarrazin, architecte au sein du Centre d’Excellence Cloud Capgemini, donne de la perspective au cloud dans ce podcast. Bénéfices d’agilité et de scalabilité, réduction des coûts et source d’innovation mais aussi freins à l’adoption seront abordés par nos deux experts. Ils reviendront aussi sur l’impact de la crise sanitaire sur l’adoption du cloud et sur la résilience des entreprises qui avaient déjà entamé leur transformation. Pour en savoir plus sur notre approche cloud, téléchargez notre livret « Transformation cloud, les clés du succès » https://www.capgemini.com/fr-fr/ressources/move2cloud-7-principes-pour-une-migration-reussie/

Dr. Lee Recht & Didier Toubia of Aleph Farms are Marc's guests on this episode of Inside Ideas. Lee's main passion and dedication lies between sustainability and innovation with a personal devotion to promote resilience in the global food systems. Dr. Recht is Currently Head of Sustainability at Aleph Farms, an Israeli-based food company that paves the cultivated meat path as leader of a global sustainable food ecosystem, working passionately to grow delicious, real beef steaks from the cells of living cows. Her recent positions include working with the Global 1000 companies, leading NGOs and high-level government officials from around the world, building them tailor made ways to help identify and implement innovative solutions according to the strategies and efforts. Lee also established and directed The Builders R&D Innovation, leading Israeli ETA hub (External Technology Acquisition) by The Coca-Cola Company, and served as a Scientific Advisor for the Energy and Clean-tech Sector at the Office of the Chief Scientist, Ministry of Economy (today: Israel Innovation Authority, IIA). Lee holds a PhD in Biotechnology from the Ben Gurion University, a B.Sc. in Food technology from the Hebrew University and an MBA specializing in Strategy and International Management. Didier is the Co-Founder and CEO of Aleph Farms, a cultivated meat company that is shaping the future of food by growing slaughter-free beef steaks directly from cow cells, preserving natural resources, and avoiding the use of antibiotics. Prior to Aleph Farms, Didier co-founded and led IceCure, which went public in 2010, and served as the CEO of NLT Spine, which was acquired by SeaSpine in 2016. Didier was trained as a Food Engineer and Biologist and holds a joint executive MBA from Kellogg and Recanati. He is also co-Founder of BlueTree and Yeap. https://aleph-farms.com

And we’re back with another special edition of In Check with Fintech in French, this time with our host for the French market Fabien Le Pichon, Senior Recruitment Consultant at Payments & Cards Network. Our guest this week is Farida Poulain, Head of Incubation at Swave. Bienvenue dans “In check with fintech”, le podcast de Payments & Cards Network, en français! Après quelques années en banque, Farida rentre dans l’univers start up il y a une dizaine d’années. Elle a occupé le poste de Directrice des Opérations chez Younited Credit (anciennement Prêt d’Union), puis chez Payplug (rachetée par Natixis). Elle a ensuite co-fondé Depopass (aujourd’hui marque BPCE) en tant que Directrice des Opérations.Fintech Addict, passionnée par la finance de demain, Farida est aujourd’hui Head of incubation au Swave, première plateforme d’innovation dédiée au fintech de Paris & Co en France.À Propos du Swave Lancée en 2017, Le Swave est la première plateforme d’innovation française à être 100 % dédiée à la fintech & l’insurtech. Née de l’initiative de l’Etat français, qui a missionné Paris&Co (agence de développement économique et d’innovation de Paris et sa Métropole) à accompagner le mieux possible les jeunes fintech & insurtech françaises. Plus d’infos: https://swave.parisandco.paris/ 

“Lorsqu’on a lancé notre e-commerce, notre stratégie était basée à 100% sur les magasins. Il fallait être capable de livrer vite sinon notre premier concurrent était le Franprix lui-même.”Alexandre Nottin, le nouvel invité du Panier, est le Directeur Digital de Franprix, l’enseigne de magasins alimentaires de proximité. Lorsqu’Alexandre a rejoint l’entreprise, en 2015, elle n’était pas digitalisée et ne proposait pas de e-commerce. Depuis, elle fonctionne comme un laboratoire d’innovation pour le groupe Casino. Très vite, Franprix a développé “Alimentaire Express”, une solution de marketplace pour faire ses courses à distance, et s’est associé à Stuart, pour livrer les clients à domicile. Aujourd’hui, Franprix compte plus de 900 points de vente, dont 90% en Île-de-France, et a comme objectif de proposer un service de livraison dans chacun de ses magasins. “En juin 2017, on a mis en place une application “couteau-suisse” qui visait à combiner ce que l’on peut retrouver en expérience magasin et notre pendant e-commerce.”Avec Laurent Kretz, fondateur de CosaVostra, ils retracent le parcours d’Alexandre Nottin et ses objectifs lorsqu’il a rejoint le groupe Casino il y a 5 ans. Il raconte comment l’enseigne s’est peu à peu ouverte au e-commerce et à la livraison à domicile en s’associant, d’abord à Cdiscount, puis à Stuart avant de lancer sa propre application en juin 2017. Alexandre explique ensuite comment Franprix a lancé, pendant le Covid 19, la possibilité de commander plus de 260 produits dans plus de 100 magasins et de se faire livrer à domicile via Deliveroo. Cette démarche lui a ainsi permis de multiplier par 10 son trafic, et par 4 ses commandes. Mais ce système dépendait énormément des magasins, il met donc en lumière leur organisation pour parvenir à gérer les stocks, en ne permettant de passer commande qu’une heure par jour au tout début. Enfin, il revient sur leurs objectifs à venir et sur leurs principaux enjeux. Et si ça ne vous suffisait pas, Alexandre livre les partenaires avec qui ils travaillent au quotidien tels que Eskimoz, ScanUp ou encore Akeneo. Ils ont également parlé d’anciens épisodes du Panier :#37 – Merci Handy : Produits cleans, licornes, arcs-en-ciels et 3 millions de produits vendus en 2019#39 – Respire : Bonnes pratiques et croissance organique pour séduire 50 000 clients en 1 an#48 – Spliiit : Évangéliser le partage d’abonnements auprès de 100 000 utilisateurs en 9 mois Et de If This Then Dev :#6 – Des rails vers le Cloud : histoire d’une migration réussie – Marie-Caroline Bénézet Pour découvrir tout ça, c’est par ici si vous préférez iTunes, par là si vous préférez Deezer ou encore ici si vous préférez Spotify.Abonnez-vous également à la newsletter !

Stacey Brown is The Founder of InsurTech Hartford. He talks about the need for businesses to be creative and collaborative, Insurtech Hartford will convene worldwide entrepreneurs on June 18 at 11 a.m. for its Innovation Challenge contest

Quatre entreprises de l’agglomération de Longueuil sont au Consumer Electronic Show, (innovation et technologies) à Las Vegas. Les gens de DEL y sont pour la première fois.

Hariraj Vijayakumar is a business leader turned chief learning officer and now an entrepreneur. I first met Hariraj when he was a learning leader at Cognizant. Hari saw the value of using analytics to improve learning outcomes much before it was popular. With a deep interest in science, Hari has been a proponent of evidence-based practice and an influential advisor in the design of our evidence-based talent management curriculum. During his time as the chief learning officer at Cognizant, he reskilled his team in evidence-based talent development and leveraged it to drive innovation. His passion for innovation, evidence-based practice, and the ability to influence his staunches critics make him exceptionally good at what he does. In our conversation, we explore all of these areas and more.

Fait comme ça, le podcast acadien où je partage mon parcours pour créer une business en ligne. Mon but est de t’empowerer à le faire toi aussi en partageant ce qui a marché et aussi mes erreurs. Dans cet épisode: Entrevue avec Eric Fournier, directeur du programme IDEeS ◦ C’est quoi ce projet et pourquoi tu devrais savoir que ça existe (et y appliquer) ◦ Le processus à suivre si tu as une idée pour un des défis et comment appliquer pour avoir jusqu’à 200 000 $ de financement ◦ Le site du programme IDEeS : https://www.canada.ca/fr/ministere-defense-nationale/programmes/idees-defense.html Si tu veux m'envoyer un message (questions, commentaires, etc.), je suis sur Twitter (@drsimonlandry) et toutes mes informations sont sur mon site web (drsimonlandry.com)!

Plast i haven är ett uppmärksammat globalt problem. Många efterfrågar en allt mer fossilfri värld och kapitalförvaltning. Få har dock svaren på hur det skall åstadkommas. Inom skogsindustrin sker en enorm utveckling, lite i det fördolda, och här finner du mängder av nya innovativa lösningar på en stor mängd av dagens klimatrelaterade problem. Är skogen det nya gröna guldet, där du bara måste vara investerad? I Catellas podcast deltog ett flertal experter inom området. Mikael Hannus Vice President Group R&D Innovation på Stora Enso, Mikael Jåfs analytiker skogssektorn Kepler Cheuvreux och förvaltare Martin Nilsson från Catella tillsammans med Mikael Wickbom från Catella som analyserar framtida möjligheter och investeringar. Riskinformation Investeringar i fondandelar är förenade med risk. Historisk avkastning är ingen garanti för framtida avkastning. De pengar som placeras i fonden kan både öka och minska i värde och det är inte säkert att du får tillbaka hela det insatta kapitalet. Ingen hänsyn är tagen till inflation. Fonderna Catella Balanserad, Catella Credit Opportunity, Catella Hedgefond och ICA-fonderna är specialfonder enligt lagen (2013:561) om förvaltare av alternativa investeringsfonder (LAIF). Catella Sverige Aktiv Hållbarhet och Catella Småbolagsfond får använda derivat och fondernas värde kan variera kraftigt över tid. Värdet på Catella Sverige Hållbart Beta kan variera kraftigt över tid. Catella Avkastningsfond får använda derivat och får ha en större andel av fonden investerad i obligationer och andra skuldförbindelser som getts ut av enskilda statliga och kommunala myndigheter och inom EES än andra värdepappersfonder, enligt 5 kap. § 8 Lag (2004:46) om värdepappersfonder. Catella Nordic Long Short Equity och Catella Nordic Corporate Bond Flex får använda derivat och får ha en större andel av fonderna investerade i obligationer och andra skuldförbindelser som getts ut av enskilda statliga och kommunala myndigheter och inom EES än andra värdepappersfonder. För mer information, fullständig informationsbroschyr, fondfaktablad, årsberättelse och halvårsredogörelse se vår hemsida catella.se/fonder alternativt telefon 08-614 25 00.

Le gouvernement fédéral s’est engagé à investir près d’un milliard de dollars sur cinq ans dans cinq projets de supergrappes pour stimuler la collaboration entre sociétés industrielles, organisations et établissements de recherche dans les secteurs à fort potentiel de croissance. Quels seront les éléments clés pour rendre ces supergrappes efficaces ? Comment pourront-elles contribuer à renforcer les écosystèmes d’innovation ? Et quelles seront les retombées d’une telle initiative pour Montréal et, plus généralement, le Québec ? Catherine Beaudry, Pascal Beauchesne et l’animatrice Ariane Krol ont discuté de ces questions lors d’un 5 à 7 de l’IRPP le mardi 12 mars 2019 au Pub L’Île Noire. Graham Fox (IRPP) et Joanne Castonguay (IRPP) ont introduit le débat. Le téléchargement est gratuit. Nous mettons en ligne de nouveaux balados chaque deuxième mercredi. Vous pouvez envoyer vos commentaires par Twitter à @IRPP.

Sie wollen kein Auto fahren, dass in der Masse der anderen Automobile untergeht? Das geht am einfachsten mit einem SUV. Der Rüsselsheimer Automobilhersteller hat gleich davon im Programm. Einen davon haben wir uns mal zum Test kommen lassen. Den Opel Grandland X 2.0 D Innovation. Darum geht es diesmal!Ich weiß, ich wiederhole mich, aber es ist nun mal so. SUVs aller Größenordnungen sind mehr und mehr gefragt, da ist jeder Autohersteller gut bedient, sie in seinem Programm zu haben! Opel kann mit dem Mokka X, dem Crossland X und dem Grandland X gleich drei dieser Fahrzeuge anbieten. Wir schauen uns heute den Grandland X mal näher an. Das Outfit!Der Grandland X ist das größte Mitglied der Opel X-Familie aus SUV- und Crossover-Modellen. Der Wagen zeigt bei einer Länge von 4.47 Metern seine sportliche Präsenz. Vor allem aber zeigt er schon in seiner Frontpartie unverkennbar, dass er ein Erzeugnis aus Rüsselsheim ist. Power und Drive!    Den Grandland X gibt es mit Benzinmotoren mit 96 kW (130 PS) und 133 kW (180 PS), dazu gibt es Dieselmotoren mit 96 kW (130 PS) und 130 kW (177 PS).  Bei den Getrieben kann man zwischen einem 6-Gang-Schaltgetriebe und einer 8-Stufen-Automatik wählen. Unsere Wahl fiel auf den 2.0 Diesel mit 130 kW (177 PS) mit der 8-Stufen-Automatik.  Der Wagen war mit einem Start/Stop-System ausgerüstet, das ist natürlich hilfreich in Sachen Verbrauch.  Dieser wurde bereits nach dem seit dem 1. September 2018 vorgeschriebenen WLTP-Messverfahren ermittelt. Im kombinierten Fahrzyklus kommen zwischen 6,0 und 6,7 Liter raus, daraus ergeben sich CO2-Emissionen  von 157- 175 g/km.  Die Beschleunigung von 0 auf 100 km/h erledigt der Grandland X 2.0 D übrigens in 9,5 Sekunden, seine Spitze erreicht er bei 211 km/h. Die Kosten!Zu meinem Leidwesen verlangen wie alle Autohändler auch die bei Opel Geld für ihre Produkte. Wer also Eigentümer eines Grandland X werden will, muss zahlen.  Der Blick in die Preisliste zeigt aktuell je 12 Benziner und Diesel in unterschiedlichen Ausstattungslinien. Los geht es bei 24.250,00 Euro, die Skala reicht derzeit bis 43.100,00 Euro. Der von uns getestete Opel Grandland X 2.0 D Innovation mit 8-Stufen-Automatik lag mit einem Einstiegspreis von 37.810,00 Euro ohne weitere Extras zugegebenermaßen im oberen Bereich.  Das ist aber angesichts der Ausstattung gerechtfertigt. Dazu gehören bereits Dinge wie der Frontkollisionswarner mit automatischer Gefahrenbremsung sowie Fußgängererkennung, Spurhalte-Assistent und Müdigkeitserkennung. Oder auch die Einparkhilfe vorn und hinten, die Zwei-Zonen-Klimatisierungsautomatik oder auch die sensorgesteuerte Heckklappe! Alle Fotos: © Opel Automobile GmbH   Diesen Beitrag können Sie nachhören oder downloaden unter:

Avec :Stéphane SEGREDO-AGUILAR / Alexandre FRAY

In the conclusion of our 2-part podcast, Meta Keijzer-de Ruijter and Jim Cooper discuss what analytics can and should be measured in eLearning. Meta Keijzer-de Ruijter graduated from the faculty of chemical engineering at TU Delft in 1992. After working in the chemical industry for several years she studied corporate education at FCE. In 2004 she returned to TU Delft as the head of the computer training department. Soon after, she developed the digital testing system at the university, overseeing software selection, establishment of a support organization, teacher training and computer exam rooms. She now works in the ICT/R&D – Innovation department, enabling her to focus on the use of advanced features in Maple T.A. and the development of in-house expertise in these advanced features.

Meta Keijzer-de Ruijter graduated from the faculty of chemical engineering at TU Delft in 1992. After working in the chemical industry for several years she studied corporate education at FCE. In 2004 she returned to TU Delft as the head of the computer training department. Soon after, she developed the digital testing system at the university, overseeing software selection, establishment of a support organization, teacher training and computer exam rooms. She now works in the ICT/R&D – Innovation department, enabling her to focus on the use of advanced features in Maple T.A. and the development of in-house expertise in these advanced features. In this first installment of our 2-part podcast, Meta sits down with Jim Cooper, President and CEO of Maplesoft and DigitalEd, to discuss strategies to bring education to everyone.

Le concept d’innovation dans le jeu vidéo est essentiel et est même un modèle du genre tant ce média est créatif. Via le prisme d’outils économiques (mais pas trop), retour sur certains jalons importants de l'histoire du jeu vidéo, ces échecs (3DO, PC-Engine GT, N-Gage) qui ont marqué les esprits, un questionnement sur l'âge d'or que l'on vit actuellement et des idées d'innovations futures.

Patrick Byrne, CEO and founder of Overstock.com, is deeply involved in the world market and the use of the internet as means of doing business. He explains how his diverse academic background has given him an incredibly unique skill set. (May 11, 2011)